226 related articles for article (PubMed ID: 23972246)
21. Board games.
Nature; 2007 Aug; 448(7153):511-2. PubMed ID: 17671461
[No Abstract] [Full Text] [Related]
22. Guest editors' note: Special issue on subgroup analysis in clinical trials.
Wang SJ; Dmitrienko A
J Biopharm Stat; 2014; 24(1):1-3. PubMed ID: 24392974
[No Abstract] [Full Text] [Related]
23. The impact of escalating regulatory requirements on the conduct of clinical research.
Gordon BG; Kessinger A; Mann SL; Prentice ED
Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
[TBL] [Abstract][Full Text] [Related]
24. FDA given new powers over data reporting to national clinical trials registry.
Roehr B
BMJ; 2012 Oct; 345():e6629. PubMed ID: 23033375
[No Abstract] [Full Text] [Related]
25. Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." The rationale for a National Institutional Review Board for neurodegenerative diseases.
Snyder PJ
Alzheimers Dement; 2010 Mar; 6(2):135-7. PubMed ID: 20298974
[TBL] [Abstract][Full Text] [Related]
26. Avoiding rejections by European ethics committees.
Donawa M
Med Device Technol; 2003 Jun; 14(5):26-8. PubMed ID: 12852119
[TBL] [Abstract][Full Text] [Related]
27. Acceptability and profile of the clinical drug trials underway in Finnish university hospitals in the 1990s: applications reviewed by ethics committees.
Keinonen T; Nieminen S; Saareks V; Saano V; Ylitalo P
Methods Find Exp Clin Pharmacol; 2001 Sep; 23(7):415-23. PubMed ID: 11771857
[TBL] [Abstract][Full Text] [Related]
28. IRB reform.
Slater EE
N Engl J Med; 2002 May; 346(18):1402-4. PubMed ID: 11986417
[No Abstract] [Full Text] [Related]
29. Cancer research and clinical trial in action: an important exercise before you embark on your study.
Carbone L; Kurtzman SH; Leong SP
Cancer Treat Res; 2007; 132():291-309. PubMed ID: 17305029
[No Abstract] [Full Text] [Related]
30. Bayesian statistics in medical devices: innovation sparked by the FDA.
Campbell G
J Biopharm Stat; 2011 Sep; 21(5):871-87. PubMed ID: 21830920
[TBL] [Abstract][Full Text] [Related]
31. Ethicists bemoan shortened clinical trial approval time.
Dove A
Nat Med; 1999 Dec; 5(12):1336. PubMed ID: 10581055
[No Abstract] [Full Text] [Related]
32. Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.
Tremaine WJ
Gastroenterol Clin North Am; 2006 Dec; 35(4):735-41. PubMed ID: 17129810
[TBL] [Abstract][Full Text] [Related]
33. IRBs, human subjects, and reporting adverse events.
Maloney DM
Hum Res Rep; 2005 Nov; 20(11):3. PubMed ID: 16358480
[No Abstract] [Full Text] [Related]
34. Stopping guidelines for an effectiveness trial: what should the protocol specify?
Tyson JE; Pedroza C; Wallace D; D'Angio C; Bell EF; Das A
Trials; 2016 May; 17(1):240. PubMed ID: 27165260
[TBL] [Abstract][Full Text] [Related]
35. The need for human data: the role of clinical trials and postmarketing surveillance in the safety assessment of macronutrient substitutes.
Forbes AL
Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S20-1; discussion S31-7. PubMed ID: 8801611
[TBL] [Abstract][Full Text] [Related]
36. US clinical-research system in need of review.
Ammann AJ
Nature; 2013 Jun; 498(7452):7. PubMed ID: 23739388
[No Abstract] [Full Text] [Related]
37. Malfunctions and adverse events associated with off-label use of biliary stents in the peripheral vasculature.
Bridges J; Maisel WH
Am J Ther; 2008; 15(1):12-8. PubMed ID: 18223348
[TBL] [Abstract][Full Text] [Related]
38. Time for new rules on human subjects research?
Dresser R
Hastings Cent Rep; 1998; 28(6):23-4. PubMed ID: 9868606
[No Abstract] [Full Text] [Related]
39. When should data and safety monitoring committees share interim results in cardiovascular trials?
Borer JS; Gordon DJ; Geller NL
JAMA; 2008 Apr; 299(14):1710-2. PubMed ID: 18398083
[No Abstract] [Full Text] [Related]
40. Continued concern: human subject protection, the institutional review board, and continuing review.
Hoffman S
Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
